Skip to main content
. 2015 Sep 4;5:13563. doi: 10.1038/srep13563

Figure 6. All three included studies estimated the relationship between OS and CDKN2A methylation.

Figure 6

(a).The pooled HR for OS showed that CDKN2A hypermethylation was associated with worse survival in PENs, HR = 4.52, 95% CI = 1.25–16.35, P = 0.02. (b). The pooled HR for OS showed that CDKN2A hypermethylation was associated with worse survival in pancreatic cancer, HR = 4.46, 95% CI = 1.37–14.53, P = 0.01.